Research is needed to help illustrate the size and nature of access gaps so that we can design better coverage policies. Ultimately, there is a need for policymakers to recognize that factors unrelated to whether an individual has a medical necessity for treatment can affect whether or not a person is likely to receive these medications, says study lead author Meghan Podolsky (SPH24), research fellow in the Department of Global Health and an SPH alum who completed the MS program in epidemiology last year
CJC-1295 CJC-1295 is a synthetic version of growth-hormone-releasing hormone (GHRH)
Many of the medications used in our study were older-generation GLP-1s that have less potent effects on weight loss
Elevated TMAO levels are linked to cardiovascular, metabolic, and neuropsychiatric disorders, impacting aging, oxidative stress, and brain function
A night cream helps seal all the ingredients in, reduces water loss from the skin and supports overnight repair